182 related articles for article (PubMed ID: 19624290)
1. Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer.
Venkitaraman R; Cook GJ; Dearnaley DP; Parker CC; Khoo V; Eeles R; Huddart RA; Horwich A; Sohaib SA
J Med Imaging Radiat Oncol; 2009 Jun; 53(3):241-7. PubMed ID: 19624290
[TBL] [Abstract][Full Text] [Related]
2. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
[TBL] [Abstract][Full Text] [Related]
3. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma.
Gutzeit A; Doert A; Froehlich JM; Eckhardt BP; Meili A; Scherr P; Schmid DT; Graf N; von Weymarn CA; Willemse EM; Binkert CA
Skeletal Radiol; 2010 Apr; 39(4):333-43. PubMed ID: 20205350
[TBL] [Abstract][Full Text] [Related]
4. Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer.
Haraldsen A; Bluhme H; Røhl L; Pedersen EM; Jensen AB; Hansen EB; Nellemann H; Rasmussen F; Morsing A
Clin Physiol Funct Imaging; 2016 Jan; 36(1):40-6. PubMed ID: 25257661
[TBL] [Abstract][Full Text] [Related]
5. Computer-assisted interpretation of planar whole-body bone scans.
Sadik M; Hamadeh I; Nordblom P; Suurkula M; Höglund P; Ohlsson M; Edenbrandt L
J Nucl Med; 2008 Dec; 49(12):1958-65. PubMed ID: 18997038
[TBL] [Abstract][Full Text] [Related]
6.
Dyrberg E; Hendel HW; Huynh THV; Klausen TW; Løgager VB; Madsen C; Pedersen EM; Pedersen M; Thomsen HS
Eur Radiol; 2019 Mar; 29(3):1221-1230. PubMed ID: 30132104
[TBL] [Abstract][Full Text] [Related]
7. Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams.
Nakanishi K; Kobayashi M; Takahashi S; Nakata S; Kyakuno M; Nakaguchi K; Nakamura H
Magn Reson Med Sci; 2005; 4(1):11-7. PubMed ID: 16127249
[TBL] [Abstract][Full Text] [Related]
8. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease.
Pasoglou V; Michoux N; Peeters F; Larbi A; Tombal B; Selleslagh T; Omoumi P; Vande Berg BC; Lecouvet FE
Radiology; 2015 Apr; 275(1):155-66. PubMed ID: 25513855
[TBL] [Abstract][Full Text] [Related]
9. Role of whole-body diffusion-weighted MRI in detecting bone metastasis.
Del Vescovo R; Frauenfelder G; Giurazza F; Piccolo CL; Cazzato RL; Grasso RF; Schena E; Zobel BB
Radiol Med; 2014 Oct; 119(10):758-66. PubMed ID: 24638912
[TBL] [Abstract][Full Text] [Related]
10. Does magnetic resonance imaging of the spine have a role in the staging of prostate cancer?
Venkitaraman R; Cook GJ; Dearnaley DP; Parker CC; Huddart RA; Khoo V; Eeles R; Horwich A; Sohaib SA
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):39-42. PubMed ID: 18993040
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
Mosavi F; Johansson S; Sandberg DT; Turesson I; Sörensen J; Ahlström H
AJR Am J Roentgenol; 2012 Nov; 199(5):1114-20. PubMed ID: 23096187
[TBL] [Abstract][Full Text] [Related]
13. Therapy monitoring of skeletal metastases with whole-body diffusion MRI.
Padhani AR; Makris A; Gall P; Collins DJ; Tunariu N; de Bono JS
J Magn Reson Imaging; 2014 May; 39(5):1049-78. PubMed ID: 24510426
[TBL] [Abstract][Full Text] [Related]
14. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
[TBL] [Abstract][Full Text] [Related]
15. Development of a computer-aided diagnostic scheme for detection of interval changes in successive whole-body bone scans.
Shiraishi J; Li Q; Appelbaum D; Pu Y; Doi K
Med Phys; 2007 Jan; 34(1):25-36. PubMed ID: 17278486
[TBL] [Abstract][Full Text] [Related]
16. Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.
Sohaib SA; Cook G; Allen SD; Hughes M; Eisen T; Gore M
Br J Radiol; 2009 Aug; 82(980):632-9. PubMed ID: 19221182
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases.
Balliu E; Boada M; Peláez I; Vilanova JC; Barceló-Vidal C; Rubio A; Galofré P; Castro A; Pedraza S
Clin Radiol; 2010 Dec; 65(12):989-96. PubMed ID: 21070903
[TBL] [Abstract][Full Text] [Related]
18. Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review.
Kalus S; Saifuddin A
Eur Radiol; 2019 Oct; 29(10):5700-5708. PubMed ID: 30915559
[TBL] [Abstract][Full Text] [Related]
19. Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa).
Lecouvet FE; Simon M; Tombal B; Jamart J; Vande Berg BC; Simoni P
Eur Radiol; 2010 Dec; 20(12):2973-82. PubMed ID: 20661742
[TBL] [Abstract][Full Text] [Related]
20. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images.
Nakanishi K; Kobayashi M; Nakaguchi K; Kyakuno M; Hashimoto N; Onishi H; Maeda N; Nakata S; Kuwabara M; Murakami T; Nakamura H
Magn Reson Med Sci; 2007; 6(3):147-55. PubMed ID: 18037795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
